Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Plasma Medicine
SJR: 0.271 SNIP: 0.316 CiteScore™: 1.9

ISSN Imprimer: 1947-5764
ISSN En ligne: 1947-5772

Plasma Medicine

DOI: 10.1615/PlasmaMed.2016015846
pages 33-45

Biofilm Inactivation and Prevention on Common Implant Material Surfaces by Nonthermal DBD Plasma Treatment

Fatma Ibis
Department of Biomedical Engineering, Izmir Katip Celebi University, Izmir, Turkey
Hakan Oflaz
Department of Biomedical Engineering, Izmir Katip Celebi University, Izmir, Turkey
Utku Kürsat Ercan
Department of Biomedical Engineering, Izmir Katip Celebi University, Izmir, Turkey


Two stainless steels (SSs)−304 and 316L−as well as a titanium-aluminum-vanadium alloy (Ti6A14V) and ultra-high-molecular-weight polyethylene (UHMWPE) are common metallic and polymeric materials used in medicine for various applications such as bone fracture fixation, dental and cardiac implants, production of medical devices. Implanted materials are highly susceptible to infections that lead may implant failure. The method used to sterilize implant materials plays an important role in the success and performance of an implant. Mechanical properties of UHMWPE are compromised as a consequence of gamma irradiation. Repetitive autoclaving of implants and surgical tools reduces material performance. Also, custom orthopedic prosthesis production requires cheap, on-site, and quick sterilization procedures. In this study we evaluated the inactivation and prevention of biofilm formation of Escherichia coli and Staphylococcus aureus on UHMWPE, a Ti6A14V, 304 SS, and 316L SS surfaces. Plasma treatment of discs was evaluated by an XTT (2,3-bis-(methoxy-4-nitro-5-sulfophenyl)- 2H-tetrazolium-5-carboxanilide]) viability assay, which showed that 95% of both bacterial biofilms were inactivated after 3 minutes of plasma treatment. For the biofilm prevention tests, UHMWPE, Ti6A14V, 304 SS, and 316L SS discs were first treated with nonthermal dielectric barrier discharge plasma; then, 1-day-old biofilms of E. coli and S. aureus were grown on the disc surfaces, and biofilm formation was similarly evaluated using an XTT assay. Plasma treatment of implant surfaces prevents biofilm formation up to 50%. Safranin assay, which was used to evaluate extracellular polymeric substances, also has shown that plasma treatment of UHMWPE, Ti6A14V, 304 SS, and 316L SS discs not only inactivates biofilms but also but also disrupts extracellular polymeric substances that are secreted by bacteria during biofilm growth.

Articles with similar content:

Bactericidal Efficacy of Dielectric Barrier Discharge Plasma on Methicillin-Resistant Staphylococcus aureus and Escherichia coli in Planktonic Phase and Colonies In vitro
Plasma Medicine, Vol.5, 2015, issue 1
Halim Ayan, Niloofar Sanaei
Plasma Medicine in Dermatology: Basic Antimicrobial Efficacy Testing as Prerequisite to Clinical Plasma Therapy
Plasma Medicine, Vol.2, 2012, issue 1-3
Sebastian Scholz, Steffen Emmert, Michael Junger, Hermann Haase, Sebastian von Podewils, Georg Daeschlein, Thomas von Woedtke
Comparative Assessment of Antifungal and Antibacterial Activities of Crude Extracts of the King Tuber Culinary-Medicinal Mushroom, Pleurotus tuber-regium (Agaricomycetes) from Cameroon
International Journal of Medicinal Mushrooms, Vol.22, 2020, issue 4
Derek Ntantoh Ndinteh, Fabrice Tsigaing Tsigain, Dominique Claude Mossebo, Tata Charlotte Mungoh, Blondo-Pascal Metsebing, Marthe Carine Djuidje Fotsing, Thierry Youmbi Fonkui, Romuald Oba
Plasma Sterilization of Root Canal Abscess
Plasma Medicine, Vol.8, 2018, issue 3
Gregory Fridman, Yuyuan Zhou, Mykola Kovalenko, Gary Nirenberg, Alexander A. Fridman, Ngoc Anh Huynh
Air-Based Coaxial Dielectric Barrier Discharge Plasma Source for Pseudomonas aeruginosa Biofilm Eradication
Plasma Medicine, Vol.7, 2017, issue 1
Diana Grondona, Leandro Giuliani, Juliana Soler-Arango, Magali Xaubet, Graciela Brelles-Mariño